Back to Top Skip to main content Skip to sub-navigation

COVID-19 Booster Shots are Now Available – What You Need to Know

Image of Containers of the Pfizer COVID-19 vaccine. Each vial contains six doses for vaccination against the COVID-19 virus. Pfizer vaccines at Moody Air Force Base, Georgia, Sept. 9, 2021. Each Pfizer vial contains six doses for vaccination against the COVID-19 virus. (U.S. Air Force photo by Senior Airman Rebeckah Medeiros)

Recommended Content:

Coronavirus and the COVID-19 Vaccine | Coronavirus | COVID-19 Vaccine Efforts

Booster shots of Pfizer-BioNTech's COVID-19 vaccine are now available at military medical treatment facility and Department of Defense vaccination sites.

Those eligible for a Pfizer-BioNTech booster shot may also get them at commercial sites, such as civilian pharmacies or doctors' offices

All COVID-19 vaccines, including Pfizer-BioNTech's booster dose, may be given at the same time as the influenza vaccine (or other vaccines which may be due).

Fully vaccinated is still defined by the Centers for Disease Control and Prevention (CDC) as completing the 2-dose series for Pfizer-BioNTech or Moderna vaccines and the 1 dose for Johnson & Johnson/Janssen vaccine.

Booster Shots

Booster shots are now formally recommended for certain groups of people under an Emergency Use Authorization, according to recent announcements from the Food and Drug Administration (FDA) and the CDC.

For now, eligibility for a booster shot is limited to those who previously received a two-dose Pfizer-BioNTech COVID-19 vaccine for their initial vaccination.

At this time, booster shots are not recommended for those who initially received the Moderna two-dose vaccine and the Johnson & Johnson/Janssen single-dose vaccine or a mixed series of vaccines. However, those two populations will likely be recommended to receive a booster shot, and a formal recommendation for that may be forthcoming later this year as additional data are reviewed, according to the CDC.

Eligibility to voluntarily receive a single Pfizer-BioNTech booster vaccine includes people who are:

  • 65 years and older and residents in long-term care facilities
  • 18 and older in long-term care settings
  • 50-64 with underlying medical conditions
  • 18-49 with underlying medical conditions based on their individual benefits and risks
  • 18-64 who are at increased risk of COVID-19 exposure and transmission because of occupational or institutional settings such as teachers, frontline health care workers and essential workers, and those incarcerated, based on their individual benefits and risks.

To become eligible for a booster shot, there is a there is a six-month waiting period after the completion of the second dose of the Pfizer-BioNTech 2-dose vaccine.

Booster doses are not currently part of the DOD or federal worker mandates for COVID-19 vaccine requirements.

Proof of an underlying condition or an occupational risk is not required to receive a booster dose at an MTF or DOD vaccination site, and self-reporting of a condition eligible for a booster shot is allowed at any site where vaccines are available.

Comirnaty

The Pfizer-BioNTech COVID-19 vaccine is also known as the "Pfizer-BioNTech Comirnaty vaccine." The initial Pfizer-BioNTech vaccine was authorized for use under an FDA Emergency Use Authorization earlier this year, and the same vaccine assumed the new name, Pfizer-BioNTech Comirnaty, when it was fully approved by the FDA on Sept. 23. The two vaccines may be used interchangeably.

The COVID-19 shot being administered
Air Force Maj. Carla Cox, 59th Medical Wing commander’s executive officer, provides a COVID-19 vaccine to a San Antonio Military Health System beneficiary at Wilford Hall Ambulatory Surgical Center, Joint Base San Antonio-Lackland, Texas. (U.S. Air Force photo by Staff Sgt. Amanda Stanford)

The Comirnaty name (pronounced koe-mir' na tee) was developed from taking the Co from COVID-19, followed by the mRNA in the middle and ending with the 'ty' as a nod to immunity and community.

Third Shot vs. Booster

There is an important distinction between "booster shots" and "an additional dose."

A booster shot of the Pfizer-BioNTech COVID-19 vaccine is recommended for certain individuals at least six months after the second dose of the two dose Pfizer-BioNTech series. A booster shot aims to increase, or "boost", waning immunity observed over time, especially in those 65 years and older and residents of long-term care facilities. A familiar analogy of a booster shot may be the tetanus booster that is recommended every 10 years.

The option for an "additional dose" of mRNA vaccine (Pfizer-BioNTech or Moderna) was recommended in August for a comparatively smaller group of people who have compromised immune systems. This, unlike the booster dose, is because the primary 2-dose series of Pfizer-BioNTech or Moderna may not have resulted in a good enough antibody response; therefore an additional dose is recommended. The timing of an "additional dose" is at least 28 days after the second dose of an mRNA vaccine.

What about Moderna or Janssen Booster Doses?

Health officials may soon make a decision about whether to expand the recommendation for a booster beyond just those who received the Pfizer-BioNTech vaccine.

Moderna has already submitted data to the FDA for booster authorization. "A decision is expected soon," National Institutes of Health Director Francis Collins said Sept. 28. Earlier in September, J&J/Janssen submitted new data in support of a booster for its vaccine.

It's Time to Get Vaccinated

Both FDA and CDC noted that the populations most vulnerable to the SARS-CoV-2 coronavirus that causes COVID-19 continue to be those who are unvaccinated, and the nation's priority should remain getting everyone vaccinated with their primary series.

The approved and authorized COVID-19 vaccines continue to be effective in reducing severe, cases, hospitalizations, and deaths, even against the dominant Delta variant.

Most COVID-19 severe cases, hospitalizations, and deaths occur among the unvaccinated, around 99% of the time.

Hospitalizations rates are 10 to 22 times higher among unvaccinated adults compared to vaccinated adults, according to the CDC.

The CDC's Advisory Committee on Immunization Practices and the FDA Vaccines and Related Biologicals Advisory Committee will continue to follow the scientific data, and evidence will inform booster shot recommendations beyond the current ones.

Experts are looking at all available data to understand how well current vaccines are working for different populations - including looking at new variants Delta and Mu - to see how they affect vaccines' effectiveness.

While the COVID-19 vaccines currently available work to prevent severe illness, hospitalization, and deaths, public health experts are starting to see reduced protection, especially among certain populations, against mild to moderate disease.

"FDA and CDC have determined these booster shots can begin, based on the latest data and evidence, after a thorough, independent and transparent process of evaluating safety and effectiveness," the White House said in a Sept. 24 statement.

You also may be interested in...

Airway Pressure Release Ventilation (APRV) (April 17, 2020)

Video
5/11/2020
Airway Pressure Release Ventilation (APRV) (April 17, 2020)

This video will explain the basics of Airway Pressure Release Ventilation, an option for mechanical ventilation, that is helpful as an oxygen salvage therapy for patients with Acute Respiratory Distress Syndrome (ARDS).

Recommended Content:

Coronavirus | Coronavirus and the COVID-19 Vaccine

Acute Respiratory Distress Syndrome Lecture (April 10, 2020)

Video
5/11/2020
Acute Respiratory Distress Syndrome Lecture (April 10, 2020)

In this lecture, the topic or Acute Respiratory Distress Syndrome is reviewed. Specific discussion on diagnosis and treatment including lung protective strategies are discussed.

Recommended Content:

Coronavirus | Coronavirus and the COVID-19 Vaccine

Ventilator Basics (ACVC) (March 19, 2020)

Video
5/11/2020
Ventilator Basics (ACVC) (March 19, 2020)

Ventilator basics (one mode) for non-intensivists

Recommended Content:

Coronavirus | Coronavirus and the COVID-19 Vaccine

Ventilator Tutorial V500/PB840 Drager (April 10, 2020)

Video
5/11/2020
Ventilator Tutorial V500/PB840 Drager (April 10, 2020)

Ventilator assembly and input of settings for two common ICU ventilators.

Recommended Content:

Coronavirus | Coronavirus and the COVID-19 Vaccine

Acid Base for the Non-intensivist (March 21, 2020)

Video
5/11/2020
Acid Base for the Non-intensivist (March 21, 2020)

This video will teach you the etiologies for the various acid-base disorders as well as teach you how to interpret an ABG with a focus on metabolic acidosis and mixed disorders. This will teach you little to nothing about buffering, organic chemistry, biochemistry, etc. This is for practical application at the bedside.

Recommended Content:

Coronavirus | Coronavirus and the COVID-19 Vaccine

Transport Vent Tutorial (ParaPAC) (March 25, 2020)

Video
5/11/2020
Transport Vent Tutorial (ParaPAC) (March 25, 2020)

Transport Vent Tutorial - ParaPAC

Recommended Content:

Coronavirus | Coronavirus and the COVID-19 Vaccine

Shock Basics for the Non-Intensivist (March 19, 2020)

Video
5/11/2020
Shock Basics for the Non-Intensivist (March 19, 2020)

Shock Basics for the Non-Intensivist...in the age of COVID-19.

Recommended Content:

Coronavirus | Coronavirus and the COVID-19 Vaccine

Sedation and Analgesia in the ICU during COVID-19 (March 31, 2020)

Video
5/11/2020
Sedation and Analgesia in the ICU during COVID-19 (March 31, 2020)

This video is intended to assist healthcare providers with the care of critically ill patients only. It is to be used as a guide ONLY for patients who have breathing tubes and are mechanically ventilated (on breathing machines). It will introduce you to sedative and analgesic medications that are used in the intensive care unit setting only. It will provide recommendations for use of sedation and analgesia in standard settings, but it will also provide recommendations for use in resource limited

Recommended Content:

Coronavirus | Coronavirus and the COVID-19 Vaccine

Sepsis In The Age of COVID-19 (April 10, 2020)

Video
5/11/2020
Sepsis In The Age of COVID-19 (April 10, 2020)

This video will review diagnosis and management of sepsis with some clarifications/alterations that apply during the COVID pandemic. This video is not all inclusive. It is meant as a refresher for non-intensivists.

Recommended Content:

Coronavirus | Coronavirus and the COVID-19 Vaccine

Ventilator Basics - Part 2 (ACPC and PS) (March 25, 2020)

Video
5/11/2020
Ventilator Basics - Part 2 (ACPC and PS) (March 25, 2020)

This video is an introduction to pressure control and pressure support ventilator settings. If you have not yet viewed 'Vent Basics for Non-Intensivists (ACVC/VAC)", please watch that video first. This video is not intended to be all encompassing. It is intended to educate non-intensivists on basic vent settings and vent mechanics.

Recommended Content:

Coronavirus | Coronavirus and the COVID-19 Vaccine

Awakening Trials, Breathing Trials, and Extubation (March 27, 2020)

Video
5/11/2020
Awakening Trials, Breathing Trials, and Extubation (March 27, 2020)

This video covers safety screens and failure criteria for Spontaneous Awakening Trials (SATs) and Spontaneous Breathing Trials (SBTs). These together form the ABCs of daily care of ICU patients on vents (Airway and Breathing Coordination). Additionally, it covers the criteria that should be met prior to attempting extubation.

Recommended Content:

Coronavirus | Coronavirus and the COVID-19 Vaccine

IV Vasoactive Medication Basics for the Non Intensivist (March 19, 2020)

Video
5/11/2020
IV Vasoactive Medication Basics for the Non Intensivist (March 19, 2020)

This video provides a refresher/introduction to the basics of inotropes and vasopressors that may be helpful in the context of treating COVID-19 patients. It is not intended to be all-encompassing.

Recommended Content:

Coronavirus | Coronavirus and the COVID-19 Vaccine

BAMCheroes appreciation

Video
4/29/2020
BAMCheroes appreciation

Our community has been a great source of support! Check out some of the positive feedback Brooke Army Medical Center has received for our incredible healthcare professionals.

Recommended Content:

Coronavirus | Coronavirus and the COVID-19 Vaccine

Video Message from LTG Ronald J. Place, MD

Video
4/24/2020
Video Message from LTG Ronald J. Place, MD

Thank you for continuing to do your part to help flatten the curve

Recommended Content:

Coronavirus | Coronavirus and the COVID-19 Vaccine

MHS Minute - Military Medicine: On the Front Lines of COVID-19

Video
4/24/2020
MHS Minute - Military Medicine: On the Front Lines of COVID-19

Agencies across the federal government are partnering up to combat COVID-19. Find out how the Military Health System is doing its part to support the U.S. response to this pandemic, while ensuring our Service members remain ready.

Recommended Content:

Coronavirus | Coronavirus and the COVID-19 Vaccine
<< < 1 2 3 4 5 > >> 
Showing results 46 - 60 Page 4 of 5
Refine your search
Last Updated: December 03, 2021

DHA Address: 7700 Arlington Boulevard | Suite 5101 | Falls Church, VA | 22042-5101

Some documents are presented in Portable Document Format (PDF). A PDF reader is required for viewing. Download a PDF Reader or learn more about PDFs.